Elona Toska, MSc, DPhil, explores drivers of HIV in pregnant women and young mothers: biology, relationships, and postpartum ...

Patients taking ACE inhibitors and ARBs saw a 16% reduction in their risk of cancer progression (HR, 0.84; 95% CI, 0.71-0.99; ...

Rural cardiovascular disparities and limited specialist access are motivating AI decision-support adoption to help determine ...

Noel T. Brewer, PhD, former ACIP member, warns that the CDC's reduction from 17 to 11 recommended immunizations lacks ...

In this episode, Overcoming Access Barriers and Step-Edit Challenges in IgA Nephropathy Care, the panelists explore the ...

Affordability dominated GLP-1 decision-making, with many paying >$250 per fill, widespread use of coupons, and strong ...

An investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist, orforglipron (Eli Lilly), demonstrated superior ...

Noel T. Brewer, PhD, former ACIP member, warns that the CDC's reduction from 17 to 11 recommended immunizations lacks transparency, which may lower uptake.

Patients with oHCM experience significant variation in cardiovascular events, health care resource use, and costs across age, sex, race, and US region.

Dose-response relationships indicated progressively larger biomarker elevations from mild to severe OSA, implicating nocturnal hypoxia severity in renal stress. Meta-analysis links obstructive sleep ...

The 340B Drug Pricing Program entitles participating hospitals and clinics (called covered entities) to purchase outpatient drugs at a substantial discount from manufacturers. Covered entities either ...

As prescription drug pricing grows increasingly complex, Eric Levin, CEO and cofounder of Scripta, says Scripta aims to simplify the process for consumers trying to find the right medication at the ...